Kalaris Therapeutics, Inc. — 8-K Filings
64 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Kalaris Therapeutics, Inc. (KLRS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Kalaris Therapeutics, Inc. has filed 64 8-K documents with the SEC since 2018. To view all SEC filings by Kalaris Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEL AM
DRS
EFFECT
POS AM
POSASR
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-21-227382 | Jul 28, 2021 | Jul 22, 2021 |
| 8-K | 8-K | 0001193125-21-172375 | May 25, 2021 | — |
| 8-K | 8-K | 0001193125-21-152681 | May 6, 2021 | — |
| 8-K | 8-K | 0001193125-21-089593 | Mar 22, 2021 | Mar 17, 2021 |
| 8-K | 8-K | 0001193125-21-037404 | Feb 11, 2021 | — |
| 8-K | 8-K | 0001193125-21-009155 | Jan 14, 2021 | — |
| 8-K | 8-K | 0001193125-20-319656 | Dec 17, 2020 | — |
| 8-K | 8-K | 0001193125-20-311893 | Dec 7, 2020 | — |
| 8-K | 8-K | 0001193125-20-311243 | Dec 7, 2020 | Dec 5, 2020 |
| 8-K | 8-K | 0001193125-20-309504 | Dec 3, 2020 | Nov 30, 2020 |
| 8-K | 8-K | 0001193125-20-289722 | Nov 10, 2020 | — |
| 8-K | 8-K | 0001193125-20-248050 | Sep 17, 2020 | — |
| 8-K | 8-K | 0001193125-20-237878 | Sep 2, 2020 | — |
| 8-K | 8-K | 0001193125-20-208027 | Aug 3, 2020 | — |